242 results
Page 4 of 13
424B5
75ym47 hl3v4ybaw
3 Jun 20
Prospectus supplement for primary offering
8:33am
6-K
EX-99
4k94fsr hk01070hmd
3 Jun 20
Current report (foreign)
8:30am
424B5
3iahi
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
tlujndy
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
k9nozuj553w3s 5q9ve
27 May 20
BioLineRx Announces Publication of Data from Ongoing
7:00am
6-K
EX-99
f8r bv4kvpxd
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-99
llu95yj
12 Mar 20
BioLineRx Reports Year-End 2019 Financial Results
7:00am
6-K
EX-99
nrg58ice712959q72
27 Feb 20
BioLineRx Announces Notice of Allowance from USPTO for Patent Covering Motixafortide (BL-8040) in Combination with The COMBAT/KEYNOTE-202 Study
7:00am
6-K
EX-99
onah6j n2efhbmy3b7p
22 Jan 20
BioLineRx Completes Recruitment in Triple Combination
7:00am
6-K
EX-99
a3hund 4k
13 Dec 19
BioLineRx Announces Updated Phase 2a Data from Triple
7:00am
6-K
EX-99
2ie4tc1wkta93 v1jy4y
5 Dec 19
BioLineRx Announces Preliminary Phase 2a Data from Triple
7:00am
6-K
EX-3
xosij4avw
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-1
45rnwbq
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-99
kf9mlav4nxnv4ymyro
25 Sep 19
BioLineRx Announces Dosing of First Patient in Part 2 of
7:00am
6-K
EX-99
8kqg0dhsn27 2vucme
3 Sep 19
BioLineRx Successfully Completes Dose-Escalation Part of
7:00am
6-K
EX-99
s3vc37
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
6-K
EX-99
01r208h5x06yt u7mco
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
6-K
EX-99
j0z145xmzpgfasu3j
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
uttqyqm
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am